Noninvasive Fibrosis Assessment in Chronic Hepatitis C Infection: An Update
- PMID: 37577224
- PMCID: PMC10412701
- DOI: 10.14218/JCTH.2022.00365
Noninvasive Fibrosis Assessment in Chronic Hepatitis C Infection: An Update
Abstract
Liver biopsy is historically the gold standard for liver fibrosis assessment of chronic hepatitis C patients. However, with the introduction and validation of noninvasive tests (NITs) to evaluate advanced fibrosis, and the direct-acting antiviral agents for treatment of chronic hepatitis C virus (HCV), the role of NITs have become even more complex. There is now need for longitudinal monitoring and elucidation of cutoff values for prediction of liver-related complication after sustained virological response. The aim of this report is to provide a critical overview of the various NITs available for the assessment of liver fibrosis in HCV patients.
Keywords: Fibrosis; Hepatitis C virus; Magnetic resonance elastography; Noninvasive serum fibrosis markers; Shear wave elastography; Steatohepatitis; Transient elastography.
© 2023 Authors.
Conflict of interest statement
GW has been an editor-in-chief of Journal of Clinical and Translational Hepatology since 2013. MS and RS have been editorial board members of Journal of Clinical and Translational Hepatology since 2013. The other authors have no conflict of interests related to this publication.
Figures

References
-
- European Association for the Study of the Liver; Clinical Practice Guideline Panel; EASL Governing Board representative; Panel members EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol. 2021;75(3):659–689. doi: 10.1016/j.jhep.2021.05.025. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources